Unicycive Therapeutics In...

0.55
0.00 (0.73%)
At close: Apr 02, 2025, 3:59 PM
0.56
1.02%
After-hours: Apr 02, 2025, 07:58 PM EDT

Unicycive Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Net Income -36.73M -30.54M -18.06M -10.02M -2.26M -2.17M -1.12M
Depreciation & Amortization 428K 284K 161K 13K n/a n/a n/a
Stock-Based Compensation 2.35M 1.77M 1.05M 966K 232K 24K n/a
Other Working Capital n/a -1.37M -89K -1.35M -98K -3K -25K
Other Non-Cash Items 5.38M 10.3M 21K 3.25M 739K 660K 308K
Deferred Income Tax n/a n/a n/a 127K n/a n/a n/a
Change in Working Capital n/a -93K 1.18M -105K -166K 305K 6K
Operating Cash Flow -28.57M -18.28M -15.65M -5.77M -1.46M -1.18M -775K
Capital Expenditures -72K -12K -2K -29K n/a n/a n/a
Acquisitions n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow -72K -12K -2K -29K n/a n/a n/a
Debt Repayment n/a n/a n/a n/a 1.42M n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid -1.09M n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 46.18M -2.65M -482K 22.38M -117K 1.17M 800K
Financial Cash Flow 45.09M 27.54M -471K 22.38M 1.44M 1.17M 800K
Net Cash Flow 16.44M 9.25M -16.12M 16.58M -15K -10K 25K
Free Cash Flow -28.65M -18.3M -15.65M -5.8M -1.46M -1.18M -775K